rugcc-kdGenetic Study of Kidney Disease by Rutgers University
This observational study by Rutgers University aims to identify genetic risk factors for kidney disease by examining the genes of participants through whole exome sequencing and genotyping.
Data Collection
Collected at a single point in time - Cross-sectionalUrogenital Diseases+11
+ Chronic Disease
+ Female Urogenital Diseases and Pregnancy Complications
Case-Control
Comparing exposures between individuals with and without disease in order to identify potential risk factors.Summary
Study start date: November 1, 2025
Actual date on which the first participant was enrolled.This study aims to explore the connection between genetics and the likelihood of developing kidney disease. It focuses on understanding how genes can influence kidney function, specifically in relation to chronic kidney disease, which affects about one in seven people in the United States. By examining the genetic factors involved, the study seeks to pave the way for new drug developments and better treatment options. A diverse group of participants is important for this study to ensure the findings are applicable to a wide range of people. Participants in this study will take part entirely online, making it convenient and accessible. They will provide information about their health through a secure online portal and submit a DNA sample using a saliva kit that can be mailed back at no cost. This process takes about 20 minutes. Participants may also choose to share data from their electronic health records, although this is optional. As a benefit, participants can receive free information about their genetic ancestry. The study keeps participants informed and engaged with short monthly newsletters.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.50000 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-Control
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * age 18 years or older * currently living in the United States * able to understand and follow written instructions in English * have access to the internet and a computer, laptop, tablet or smart phone * willing to provide written informed consent for participation * willing to provide DNA via a saliva sample using a collection kit mailed to the study participant's home * willing to complete a survey with questions about health related to the study of kidney disease Exclusion Criteria: * Not able to meet or fulfill any of the inclusion criter
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Rutgers, The State University of New Jersey
Piscataway, United StatesOpen Rutgers, The State University of New Jersey in Google Maps